Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofPemetrexed Disodium For Injection from Surat, Gujarat, India. Pemetrexed Disodium For Injection Low blood cell counts, as measured by a complete blood count. This is a dose-limiting toxicity.
Tags: Pemetrexed Disodium For Injection manufacturer, Pemetrexed DisodiumFor Injection exporter, Pemetrexed Disodium For Injection supplier,and Pemetrexed Disodium For Injection, whogmp approved Pemetrexed Disodium For Injectionmanufacturer and supplier, Pemetrexed Disodium For Injection distributor,Pemetrexed Disodium For Injection shipper, Pemetrexed Disodium For Injection500 mgPemetrexed Disodium For Injection 500 mgsupplier, Pemetrexed Disodium For Injection500 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifesciencePemetrexed Disodium ForInjection export to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Targeted Therapy for CancerPemetrexed Disodium For Injection is dedicated to managing malignant pleural mesothelioma and non-small cell lung cancer. As an antineoplastic agent, it targets rapidly dividing cancer cells, inhibiting their growth and spread, thus supporting improved treatment outcomes when used under professional supervision.
Safe Administration and DosageThe medication must be reconstituted with a suitable diluent by trained healthcare providers and administered intravenously. Adhering to strict dosage instructions is crucial for patient safety and therapeutic effectiveness. This injection is solely for prescription use and is not available for over-the-counter purchase.
Quality Assurance and Shelf StabilityManufactured, exported, and supplied across India, Pemetrexed Disodium is produced with rigorous quality standards and stable shelf life. Proper storage at cool, dry conditions preserves the product for up to two years, making it reliable for hospitals and clinics.
FAQ's of Pemetrexed Disodium For Injection:
Q: How should Pemetrexed Disodium For Injection be administered?
A: Pemetrexed Disodium should be given intravenously after reconstitution with a suitable diluent. Administration must be performed by a healthcare professional in a clinical setting.
Q: What cancers is Pemetrexed Disodium used to treat?
A: This medication is indicated for the treatment of malignant pleural mesothelioma and non-small cell lung cancer, as determined by your physician.
Q: When should the medication be reconstituted for use?
A: Pemetrexed Disodium should be reconstituted immediately before use, as directed by the prescribing information, ensuring maximum potency and patient safety.
Q: Where should this injection be stored before use?
A: The product should be stored in a cool, dry place, away from direct light and moisture, to maintain its efficacy until the expiration date.
Q: What is the process for preparing Pemetrexed Disodium for administration?
A: A healthcare professional will reconstitute the lyophilized powder with an appropriate sterile diluent immediately before intravenous administration, following all safety protocols.
Q: What are the benefits of using Pemetrexed Disodium For Injection?
A: This injection offers targeted therapy against selected cancers, potentially improving survival rates and quality of life for patients diagnosed with mesothelioma or non-small cell lung cancer.